SYH2068 injection for high lipoprotein(a) in adults
Part of Heart & circulation clinical trials.
This trial tests a new injection (SYH2068) designed to lower lipoprotein(a), a type of cholesterol linked to heart disease. You may qualify if you have high lipoprotein(a) levels and either existing heart disease or significant risk factors for it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- High lipoprotein(a) levels (confirmed by blood test)
- Either established heart/blood vessel disease OR assessed as moderate-to-high risk for it
- No major heart problems or surgery in the past 3 months
- No cancer diagnosis in the past 5 years
- Willing to stay on the same doses of other cholesterol medications (or not start new ones)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injection called SYH2070 for people with high triglycerides and high LDL cholesterol. The goal is to see if a single dose is safe and how the body processes the medication. It is for people who have not been on cholesterol-lowering drugs recently.
This study tests a new injectable medication (SYH2070) designed to lower cholesterol in people with homozygous familial hypercholesterolemia—a genetic condition that causes extremely high cholesterol levels despite treatment. The goal is to see if this drug safely reduces cholesterol better than current options.
This trial tests a new investigational medicine (SYH2053) for people with high cholesterol or mixed hyperlipidemia who are already on cholesterol-lowering therapy but still have high levels of 'bad cholesterol' (LDL-C). The goal is to see if this add-on treatment can help lower cholesterol further and reduce heart disease risk.
This trial tests an investigational injection called SYH2070 to lower cholesterol and triglycerides in people who are already on a stable statin therapy. It may be a new option for those with mixed hyperlipidemia who need additional lipid control.
This trial tests a new medicine called SRSD216 for people with high levels of lipoprotein (a), a type of fat in the blood that can increase heart disease risk. The study aims to see if the drug is safe and effective at lowering these levels.
This trial tests a new medication called SYH2053 for people with high cholesterol or mixed high cholesterol and triglycerides. If you have high LDL cholesterol and are not taking strong cholesterol medicines, you may be able to join. The study will see if this drug is safe and works well.
Hear when a new Adult Participants With Elevated Lipoprotein(a) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.